Suppression of intestinal polyp development by low-fat and high-fiber diet in Apc(Δ716) knockout mice

Carcinogenesis

Volumn 18, Issue 10, 1997, Pages 1863-1865

  Hioki, Kyoji ^a   Shivapurkar, Narayan ^b,e   Oshima, Hiroko ^c   Alabaster, Oliver ^b   Oshima, Masanobu ^c   Taketo, Makoto M ^d  

^a CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c TAIHO PHARMACEUTICAL CO LTD   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e Inst for Chemoprevention Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM INTAKE; CANCER INCIDENCE; CODON; COLON; CONTROLLED STUDY; DIETARY FIBER; DIETARY INTAKE; DRUG INDUCED CANCER; FAMILIAL CANCER; FAT INTAKE; GASTROINTESTINAL POLYPOSIS; GENE MUTATION; HETEROZYGOSITY LOSS; INTESTINE POLYP; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE;

ANIMALS; DIET, FAT-RESTRICTED; DIETARY FATS; DIETARY FIBER; FEMALE; GENES, APC; INTESTINAL POLYPS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 0031417424     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.10.1863     Document Type: Article

References (23)

1. American Cancer Society (1994) 1993 Cancer Facts and Figures. American Cancer Society, New York.
2. Weisburger, J.H., Reddy, B.S. and Wynder, E.L. (1977) Colon cancer: its epidemiological and experimental production. Cancer, 40, 2414-2420.
3. Greenwald, P. and Lanza, E. (1986) Role of dietary fiber in the prevention of cancer. In Devita, V.T., Hellman, S. and Rosenberg, S.A. (eds.) Important Advances in Oncology. J.B. Lippincott, Philadelphia, PA, pp. 37-54.
4. Doll, R. and Peto, R. (1981) The causes of cancer: quantitative assessment of avoidable risk of cancer in the United States today. J. Natl Cancer Inst., 66, 1191-1308.
5. Byers, T. and Graham, S. (1984) The epidemiology of diet and cancer. In Klein, G. and Weinhouse, S. (eds) Advances in Cancer Research. Academic Press, New York, vol. 41, pp. 1-69.
6. Shivapurkar, N., Tang, Z.C. and Alabaster, O. (1992) The effect of high-risk and low-risk diets on aberrant crypts and colonic tumor formation in Fischer-344 rats. Carcinogenesis, 13, 887-890.
7. Kinzler, K.W. and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell, 87, 159-170.
8. Hamilton, S.R. (1993) Molecular genetics of colorectal carcinoma. Cancer, 70, 1216-1221.
9. Fearon, E.R. and Jones, P.A. (1992) Progression towards a molecular description of colorectal cancer development. FASEB J., 6, 2783-2790.
10. Oshima, M., Oshima, H., Kitagawa, K., Kobayashi, M., Itakura, C. and Taketo, M. (1995) Loss of Apc heterozygosity in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl Acad. Sci. USA, 92, 4482-4486.
11. Oshima, M., Oshima, H., Kobayashi, M., Tsutsumi, M. and Taketo, M.M. (1995) Evidence against dominant negative mechanisms of intestinal polyp formation by Apc gene mutations. Cancer Res., 55, 2719-2722.
12. Δ716 knockout mice. Mol. Carcinogen., 15, 11-17.
13. Δ716 knockout mice. Carcinogenesis, 16, 2605-2607.
14. Δ716 knockout mice. Cancer Res., 57, 1644-1649.
15. Richter, F., Newmark, H.L., Richter, A., Leung, D. and Lipkin, M. (1995) Inhibition of Western-diet induced hyperproliferation and hyperplasia in mouse colon by two sources of calcium. Carcinogenesis, 16, 2685-2689.
16. Moser, A.R., Pitot, C. and Dove, W.F. (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science, 247, 322-324.
17. Kennedy, A.R., Beazer-Barclay, Y., Kinzler, K.W. and Newberne, P.M. (1996) Suppression of carcinogenesis in the intestine of Min mice by the soyabean-derived Bowman-Birk inhibitor. Cancer Res., 56, 679-682.
18. Kennedy, A.R. (1994) Prevention of carcinogenesis by protease inhibitors. Cancer Res., 54, 1999s-2005s.
19. Boolbol, S.K., Dannenber, A.J., Chadburn, A., Martucci, C., Guo, X.J., Romonetti, J.T., Abreu-Goris, M., Newmark, H.L., Lipkin, M.L., DeCosse, J.J. and Bertagnolli, M.M. (1996) Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in murine model of familial adenomatous polyposis. Cancer Res., 56, 2556-2560.
20. Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res., 56, 710-714.
21. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-809.
22. Dierich, W.F., Lander, E.S., Smith, J.S., Moser, A.R., Gould, K.A., Luongo, C., Borenstein, N. and Dove, W. (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell, 75, 631-639.
23. Smith, A.J., Stern, H.S., Penner, M., Hay, K., Mitri, A., Bapat, B.V. and Gallinger, S. (1994) Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res., 54, 5527-5530.